Event details:
Two researchers from the METRINO project will present selected project outcomes at ETPN2026, the 21st Annual Event of the European Technology Platform on Nanomedicine, taking place from 17 to 19 June 2026 at RCSI Dublin.
Organised by ETPN and hosted by RCSI, ETPN2026 will bring together the European nanomedicine community for three fully in-person days of science, clinical perspective, translation, networking and collaboration. The event is designed to connect researchers, clinicians, technology developers, startups, SMEs, industry leaders, investors and policy stakeholders working across nanomedicine and the broader HealthTech landscape.
METRINO will be represented in the European Projects in Nanomedicine session, opening the final day of the conference on Friday 19 June at RCSI Dublin. This compact European-facing block will give visibility to current collaborative initiatives, project dynamics and concrete examples of nanomedicine activity across Europe.
Caterina Minelli, Principal Scientist at the National Physical Laboratory, United Kingdom, will present “Advances and translation of chemical spectroscopy methods for lipid-based particles”.
Her talk will focus on advanced chemical spectroscopy approaches for liposomes and lipid nanoparticles, including cryogenically assisted XPS, ToF-SIMS and Raman-based methods. The presentation will highlight how these techniques can support more reliable characterisation of chemically and structurally complex nanomedicines, with relevance for industrial applicability, sustainability and ongoing standardisation efforts.
Lavinia Rita Doveri, Postdoctoral Researcher at the University of Pavia, Italy, will present “From nano to bulk: multiscale characterization of chemical homogeneity in functional nanomaterials”.
Her presentation will explore how chemical composition and homogeneity in metal-based nanoparticle systems depend on the analytical scale, and how complementary nano, micro and bulk measurements can help integrate data across techniques. This work supports more robust interpretation of nanoformulation composition and contributes to the development of fit-for-purpose methods relevant to industry and future regulatory confidence.
Together, these two talks offer the METRINO community a timely opportunity to discover some of the project’s final outcomes as it approaches completion. By addressing the characterisation of both lipid based particles and metal based nanoformulations, the presentations will show how metrology can support better comparability of data, more reliable analytical methods and stronger foundations for the translation of innovative nanomedical products.
For METRINO partners, collaborators and stakeholders, ETPN2026 will be an excellent opportunity to follow the final scientific outputs of the project, connect with the wider European nanomedicine community and discuss how these results can continue to support future research, standardisation and regulatory dialogue.
The full conference programme is now available on the ETPN2026 website and registrations are still open.
A limited number of poster abstract submissions are also still open on a first come, first served basis. Early career researchers, PhD students, young scientists and project partners are especially encouraged to use this opportunity to present their work in Dublin.
Explore the programme, register and submit your poster abstract on the ETPN2026 website.
